Zealand Pharma
The US Director, HEOR & RWE will lead the design, execution, and communication of health economics and outcomes research strategies for the company's global metabolic health portfolio. This role will generate real‑world, clinical, and economic evidence to demonstrate product value to payers, providers, patients, and policymakers, and will translate complex data into actionable insights for commercial and clinical decision‑making.
Headquarters
Søborg, Hovedstaden, Denmark
Company Size
201-500 employees
Founded
1998
N/A
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Zealand Pharma.
Right around the average for this role
Senior Director, HEOR/RWE
Revolution Medicines
Senior Manager, HEOR/RWE, Neurology
Servier
Associate Director, HEOR/RWE, Tovorafenib
Servier
Senior Director, HEOR/RWE
Revolution Medicines
Director, Payer Economics & HEOR Strategy
Twin Health
Associate Director, HEOR/RWE (Emi-Le and Solid Tumor Pipeline)
Servier